10-K: Gyrodyne LLC Navigates Entitlements and Liquidation Amidst Legal Challenges and Market Volatility

Gyrodyne LLC is focused on enhancing property values through entitlements and strategic sales, while managing legal challenges and macroeconomic uncertainties as it moves towards liquidation.

Summary

• Gyrodyne LLC is managing a portfolio of medical office and industrial properties in New York, aiming to maximize value through entitlements and strategic sales.
• The company intends to dissolve after selling all real property assets, settling debts, and distributing proceeds to shareholders.
• The process involves risks and uncertainties, making it impossible to predict the exact amount or timing of distributions.
• Gyrodyne's strategy includes enhancing the value of its Flowerfield and Cortlandt Manor properties by pursuing entitlements to increase development flexibility.
• The company is also managing legal challenges, including an Article 78 Proceeding related to the Flowerfield subdivision application.
• The company estimates a cash balance of approximately $30.72 million by December 31, 2025, prior to any future special distributions, which equates to approximately $19.51 per share based on 1,574,308 common shares outstanding.
• The estimated net assets in liquidation would be $35,463,133 or $16.12 per share based on 2,199,308 shares outstanding inclusive of the issuance of shares and net proceeds from the Rights Offering.
• The company incurred approximately $449,000 in land entitlement costs in 2023 and estimates an additional $1.21 million through 2025.
• The company believes subdivision approval will be received in mid-2024 for Flowerfield, and could be received for Cortlandt Manor in mid-2025.
• The company is managing the impact of public health and macroeconomic factors, including the COVID-19 pandemic, inflation, and interest rate hikes.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company is making progress on entitlements and has secured additional capital, it faces significant legal challenges and macroeconomic risks that could impact its liquidation timeline and distributions. The sentiment is neutral to slightly negative due to the uncertainties and potential for delays.

Positives

• The company is actively pursuing entitlements to enhance property values.
• The company has a clear plan for liquidation and distribution of assets.
• The company has secured additional capital through a rights offering.
• The company has a high occupancy rate of 86% across its properties.
• The company has a strategy to extend leases and improve cash flow.

Negatives

• The company is facing legal challenges that could delay the liquidation process.
• The company is subject to macroeconomic risks, including inflation and interest rate hikes.
• The company's timeline for completing the liquidation process is subject to factors outside of its control.
• The company's estimated distributions are based on assumptions and could be lower than expected.
• The company's properties are subject to risks associated with real estate ownership and management.

Risks

• Delays or denials of required entitlements and permits could adversely impact property enhancement plans.
• Community opposition could hinder efforts to obtain entitlements and enhance property values.
• The Article 78 Proceeding could further extend the timeline for completing the process of securing entitlements and selling properties.
• The company may not be able to find buyers for its properties at expected sales prices.
• The company's shareholders may be liable to creditors if reserves are inadequate.
• Adverse developments in the financial services industry could affect the company's access to funding.
• The company's properties are subject to risks associated with the healthcare industry.
• The company is subject to risks associated with proxy contests and other actions of activist shareholders.
• The company is subject to risks associated with renovations and capital improvements.
• Cybersecurity risks and cyber incidents may adversely affect the company's business.
• The company's mortgage indebtedness could adversely impact the value of shareholders investment.
• Changes in federal tax law could adversely affect the tax treatment of distributions to shareholders.
• The company is subject to risks stemming from the New York State budgets.
• The company is subject to risks associated with the financial condition of its tenants.
• The company is subject to risks associated with the Coronavirus pandemic.

Future Outlook

Gyrodyne intends to complete the disposition of its real property assets by the end of 2025, after which it will settle debts and distribute proceeds to shareholders. The company is focused on maximizing the value of its properties through entitlements and strategic sales, while managing legal challenges and macroeconomic uncertainties.

Management Comments

• The Board believes the aforementioned strategy will increase the aggregate value for such properties as a whole.
• The Board believes the process of negotiating purchase agreements, securing final approvals and consummating the sale of our properties will culminate by year-end 2025.
• The Company intends to aggressively market its properties and negotiate contracts in an effort to complete the process as soon as practicable with the ultimate timeline being largely dependent on factors outside the Companys control.

Industry Context

The company operates in the real estate sector, specifically managing medical office and industrial properties. The healthcare industry is subject to substantial regulation and faces increased regulation particularly relating to fraud, waste and abuse, cost control and healthcare management. The company is also impacted by broader economic trends, including inflation, interest rate hikes, and the shift towards remote working and telemedicine.

Comparison to Industry Standards

• Gyrodyne's strategy of pursuing entitlements to increase property value is a common practice in the real estate development industry, similar to companies like Howard Hughes Corporation or Brookfield Properties.
• The company's focus on medical office space aligns with trends in the healthcare real estate sector, where demand for such properties remains relatively stable, similar to companies like Healthcare Trust of America or Physicians Realty Trust.
• The company's liquidation plan is unique, as most real estate companies operate on a going concern basis, but it is similar to companies that have undergone strategic asset sales or restructuring, such as General Growth Properties during its bankruptcy.
• The company's occupancy rate of 86% is within the range of industry averages for commercial real estate, but it is important to note that the company is not actively seeking to increase occupancy as it is focused on liquidation.
• The company's estimated cash balance of $30.72 million by December 31, 2025, is a key metric for investors, but it is important to note that this is an estimate and could be impacted by various factors, including the timing of property sales and legal challenges.

Management Changes

Corporate Governance

Legal Proceedings

• The company is defending against an Article 78 Proceeding challenging the Flowerfield subdivision approval.
• The company is a party to various legal proceedings in the normal course of business, but management considers that any loss resulting from such proceedings will not be material.

Related Party Transactions

• The company has various leasing arrangements with a not-for-profit organization of which the company's Chairman, Paul Lamb, serves as Chairman and a director but receives no compensation or any other financial benefit.

Stakeholder Impact

• Shareholders are impacted by the company's liquidation plan and the potential for distributions.
• Employees are impacted by the company's retention bonus plan and potential severance.
• Tenants are impacted by the company's management of its properties and lease terms.
• Creditors are impacted by the company's ability to settle debts and claims.
• The local communities are impacted by the company's development plans and the potential for economic growth.

Next Steps

• The company will continue to pursue entitlements for its Flowerfield and Cortlandt Manor properties.
• The company will continue to defend against the Article 78 Proceeding.
• The company will continue to market its properties and negotiate contracts for their sale.
• The company will continue to manage its cash flow and operating expenses.
• The company will continue to monitor the impact of macroeconomic factors on its business.

Key Dates

Keywords

real estate, entitlements, liquidation, property development, medical office, industrial properties, legal proceedings, shareholder distributions, land use, zoning, financial performance